1. Home >
  2. M&A >
  3. Divestiture >
  4. Switzerland >
  5. ADVANZ PHARMA Acquires Covis Pharma Sàrl

M&A Deal Summary

ADVANZ PHARMA Acquires Covis Pharma Sàrl

On March 15, 2015, ADVANZ PHARMA acquired healthcare services company Covis Pharma Sàrl for 1.2B USD

Acquisition Highlights
  • This is ADVANZ PHARMA’s 1st transaction in the Healthcare Services sector.
  • This is ADVANZ PHARMA’s 2nd largest (disclosed) transaction.
  • This is ADVANZ PHARMA’s 1st transaction in Switzerland.

M&A Deal Summary
Date 2015-03-15
Target Covis Pharma Sàrl
Sector Healthcare Services
Buyer(s) ADVANZ PHARMA
Deal Type Divestiture
Deal Value 1.2B USD

Target

Covis Pharma Sàrl

Luxembourg, Switzerland
Covis Pharma is a specialty pharmaceutical company providing therapeutic solutions to patients. Covis markets a portfolio of U.S. prescription products through its U.S. sales and distribution affiliate, Covis Pharmaceuticals, Inc. which is headquartered in Cary, North Carolina.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

ADVANZ PHARMA

London, United Kingdom
Category Company
Founded 1963
Sector Life Science
Employees675
Revenue 508M USD (2019)
DESCRIPTION

ADVANZ PHARMA is a specialty pharmaceutical company with a strategic focus on complex medicines with direct sales access in Europe and a global distribution network. ADVANZ PHARMA was founded in 1963 and is based in London, United Kingdom.

DEAL STATS #
Overall 3 of 6
Sector: Healthcare Services M&A 1 of 1
Type: Divestiture M&A Deals 2 of 3
Country: Switzerland M&A 1 of 1
Year: 2015 M&A 1 of 2
Size (of disclosed) 2 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-03-20 Donnatal

United States

Donnatal provides Donnatal, an adjunctive therapy in the treatment of irritable bowel syndrome ("IBS") and acute enterocolitis. It comes in two formulations: immediate release Donnatal Tablets, and immediate release Donnatal Elixir, a liquid.

Buy $200M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-09-08 Amdipharm Mercury Co. - AMCo.

Croydon, United Kingdom

Amdipharm Mercury (AMCo) is an international speciality pharmaceuticals company delivering high quality medicines with a customer focus in 112 territories.

Buy $3.5B
Mergr

Solution for

Product

Company

Legal